import type { BlogArticle } from '../blog-types';

export const article: BlogArticle = {
  slug: "peptide-dosage-calculator-weight-based-guide",
  title: "Peptide Dosage Calculator: Weight-Based Dosing, Unit Conversions, and Reconstitution Math",
  description:
    "A practical reference guide for researchers calculating weight-based peptide doses, converting mcg to IU, determining reconstitution volumes, and computing injection volumes from vial concentrations.",
  category: "Research Fundamentals",
  readMinutes: 12,
  publishedAt: "2026-06-08",
  ogImage: "/og-image.jpg",
  body: [
    {
      type: "paragraph",
      text: "Precise dosage calculation is one of the most error-prone aspects of peptide research. Mistakes in reconstitution volume, unit conversion, or injection volume calculation can introduce significant variance into study results — and potentially compromise subject safety in animal models. This guide provides a systematic framework for the math that researchers need to perform correctly, every time.",
    },
    {
      type: "heading",
      text: "The Core Formula: Weight-Based Dosing",
    },
    {
      type: "paragraph",
      text: "Most preclinical peptide research protocols express doses in micrograms per kilogram of body weight (mcg/kg). Converting this to an actual injection volume requires working through a consistent calculation chain.",
    },
    {
      type: "subheading",
      text: "Step 1: Determine the Total Dose in Micrograms",
    },
    {
      type: "paragraph",
      text: "Total dose (mcg) = Dose rate (mcg/kg) × Subject body weight (kg)",
    },
    {
      type: "paragraph",
      text: "Example: A protocol specifies 200 mcg/kg for a 0.25 kg rat.\nTotal dose = 200 mcg/kg × 0.25 kg = 50 mcg",
    },
    {
      type: "subheading",
      text: "Step 2: Determine the Stock Concentration (mcg/mL)",
    },
    {
      type: "paragraph",
      text: "After reconstitution, the stock concentration determines how much volume contains the target dose. The formula is:",
    },
    {
      type: "paragraph",
      text: "Stock concentration (mcg/mL) = Amount of peptide in vial (mcg) ÷ Volume of diluent added (mL)",
    },
    {
      type: "paragraph",
      text: "Example: A 5 mg (5,000 mcg) vial reconstituted with 2.0 mL bacteriostatic water:\nConcentration = 5,000 mcg ÷ 2.0 mL = 2,500 mcg/mL",
    },
    {
      type: "subheading",
      text: "Step 3: Calculate the Injection Volume",
    },
    {
      type: "paragraph",
      text: "Injection volume (mL) = Total dose (mcg) ÷ Stock concentration (mcg/mL)",
    },
    {
      type: "paragraph",
      text: "Continuing the example above:\nInjection volume = 50 mcg ÷ 2,500 mcg/mL = 0.02 mL (20 µL)",
    },
    {
      type: "callout",
      text: "For small injection volumes (under 0.05 mL), consider diluting the stock solution further to reduce pipetting error. A secondary dilution of 1:10 would yield 250 mcg/mL, making 0.02 mL doses become 0.2 mL — a much more practical volume for standard insulin syringes.",
    },
    {
      type: "heading",
      text: "Unit Conversions: The Peptide Researcher's Reference",
    },
    {
      type: "paragraph",
      text: "Peptide quantities are expressed across multiple units depending on context — mass-based (mcg, mg), volume-based (mL, µL), or activity-based (IU for some compounds). Confusion between these is a common source of error.",
    },
    {
      type: "subheading",
      text: "Mass Units",
    },
    {
      type: "table",
      headers: ["Unit", "Abbreviation", "Equivalence"],
      rows: [
        ["Milligram", "mg", "1 mg = 1,000 mcg"],
        ["Microgram", "mcg or µg", "1 mcg = 0.001 mg"],
        ["Nanogram", "ng", "1 ng = 0.001 mcg = 0.000001 mg"],
        ["Picogram", "pg", "1 pg = 0.001 ng (used in assay concentrations)"],
      ],
    },
    {
      type: "subheading",
      text: "Volume Units",
    },
    {
      type: "table",
      headers: ["Unit", "Abbreviation", "Equivalence"],
      rows: [
        ["Milliliter", "mL", "1 mL = 1 cc = 1,000 µL"],
        ["Microliter", "µL or uL", "1 µL = 0.001 mL"],
        ["Insulin unit (insulin syringe)", "U or IU", "100 U = 1 mL on a U-100 syringe"],
      ],
    },
    {
      type: "subheading",
      text: "Reading Insulin Syringes for Non-Insulin Peptides",
    },
    {
      type: "paragraph",
      text: "Many researchers use U-100 insulin syringes for peptide administration because they offer precise small-volume measurement. However, the syringe markings are calibrated for insulin — not volume — which causes confusion.",
    },
    {
      type: "paragraph",
      text: "On a U-100 insulin syringe: 100 units = 1 mL. Therefore:\n• 10 units on the syringe = 0.1 mL\n• 20 units = 0.2 mL\n• 50 units = 0.5 mL",
    },
    {
      type: "paragraph",
      text: "To use an insulin syringe for peptide measurement, simply read the unit marks as tenths of a milliliter — or use the conversion: Units on syringe ÷ 100 = mL.",
    },
    {
      type: "heading",
      text: "Common Reconstitution Scenarios",
    },
    {
      type: "paragraph",
      text: "The choice of reconstitution volume directly determines working concentration. Here are common scenarios researchers encounter:",
    },
    {
      type: "table",
      headers: ["Vial Size", "Diluent Added", "Resulting Concentration", "Dose per 10 units (0.1 mL)"],
      rows: [
        ["5 mg (5,000 mcg)", "1.0 mL", "5,000 mcg/mL", "500 mcg"],
        ["5 mg (5,000 mcg)", "2.0 mL", "2,500 mcg/mL", "250 mcg"],
        ["5 mg (5,000 mcg)", "5.0 mL", "1,000 mcg/mL", "100 mcg"],
        ["10 mg (10,000 mcg)", "2.0 mL", "5,000 mcg/mL", "500 mcg"],
        ["10 mg (10,000 mcg)", "5.0 mL", "2,000 mcg/mL", "200 mcg"],
        ["2 mg (2,000 mcg)", "1.0 mL", "2,000 mcg/mL", "200 mcg"],
        ["2 mg (2,000 mcg)", "2.0 mL", "1,000 mcg/mL", "100 mcg"],
      ],
    },
    {
      type: "paragraph",
      text: "Choose a reconstitution volume that results in a working concentration producing injection volumes of 0.05–0.5 mL per dose. This range is practical for subcutaneous administration, minimizes measurement error, and is within acceptable volumes for standard injection sites.",
    },
    {
      type: "heading",
      text: "Species-Specific Dosing Adjustments",
    },
    {
      type: "paragraph",
      text: "Preclinical peptide doses derived from rodent research do not translate linearly to other species due to metabolic scaling. Researchers designing multi-species protocols should apply allometric scaling corrections.",
    },
    {
      type: "subheading",
      text: "Allometric Scaling Formula",
    },
    {
      type: "paragraph",
      text: "Human Equivalent Dose (HED) = Animal dose (mg/kg) × (Animal weight in kg ÷ Human weight in kg)^0.33",
    },
    {
      type: "paragraph",
      text: "A simpler approximation using FDA-recommended Km factors:\nHED (mg/kg) = Animal dose (mg/kg) × (Animal Km ÷ Human Km)",
    },
    {
      type: "table",
      headers: ["Species", "Km Factor", "Average Weight Used"],
      rows: [
        ["Mouse", "3", "0.02 kg"],
        ["Rat", "6", "0.15 kg"],
        ["Rabbit", "12", "1.8 kg"],
        ["Monkey", "37", "3 kg"],
        ["Human (adult)", "37", "60 kg"],
      ],
    },
    {
      type: "paragraph",
      text: "Example: A rat study used 500 mcg/kg BPC-157 subcutaneously. Allometric HED:\n• Rat Km = 6, Human Km = 37\n• HED = 500 mcg/kg × (6/37) = ~81 mcg/kg\n• For a 70 kg human: 81 × 70 = ~5,670 mcg total",
    },
    {
      type: "callout",
      text: "Allometric scaling is an approximation tool for research design, not a clinical dosing recommendation. It does not account for species differences in receptor pharmacology, metabolic pathways, or peptide stability.",
    },
    {
      type: "heading",
      text: "Concentration Verification: Spotting Reconstitution Errors",
    },
    {
      type: "paragraph",
      text: "Reconstitution errors are among the most common mistakes in peptide research protocols. The following checks help verify accuracy before administration.",
    },
    {
      type: "list",
      items: [
        "Visual inspection: reconstituted peptides should be clear to slightly opalescent; cloudiness, particulates, or color suggest contamination or degradation",
        "Bubble check: do not shake vigorously; roll gently to avoid foaming which can damage peptide structure",
        "Volume verification: draw the expected volume and confirm it matches the syringe calibration at the expected mark",
        "Concentration double-check: recalculate from first principles before the first administration in any new batch",
        "pH consistency: if using acetic acid as diluent (required for some peptides like CJC-1295 DAC), verify final pH is appropriate",
      ],
    },
    {
      type: "heading",
      text: "Calculating Total Research Supply Requirements",
    },
    {
      type: "paragraph",
      text: "Before beginning a study, calculate total peptide required to avoid mid-protocol stock interruptions:",
    },
    {
      type: "paragraph",
      text: "Total peptide needed = Dose per subject (mcg) × Number of subjects × Doses per day × Study duration (days) × Overage factor (recommend 1.15–1.20 for losses to syringe dead space and reconstitution)",
    },
    {
      type: "paragraph",
      text: "Example: 10 rats, 200 mcg/kg, 0.30 kg average, twice daily, 28 days:\n• Per dose: 200 × 0.30 = 60 mcg\n• Per rat per day: 60 × 2 = 120 mcg\n• 10 rats, 28 days: 120 × 10 × 28 = 33,600 mcg = 33.6 mg\n• With 1.15 overage: 33.6 × 1.15 = ~38.6 mg needed\n• Order: 4 × 10 mg vials = 40 mg (adequate)",
    },
    {
      type: "heading",
      text: "Quick Reference: Peptide Research Dose Ranges",
    },
    {
      type: "paragraph",
      text: "The following ranges are drawn from published preclinical literature. They are not clinical recommendations and do not account for inter-study variability in model selection or administration route.",
    },
    {
      type: "table",
      headers: ["Compound", "Published Preclinical Range", "Common Route", "Frequency in Studies"],
      rows: [
        ["BPC-157", "1–10 mcg/kg (rodent)", "SC or oral", "Once or twice daily"],
        ["TB-500 (Tβ4)", "2.5–25 mg/kg (rodent)", "IP or SC", "Every 3–7 days"],
        ["GHK-Cu", "1–10 mg/kg", "SC or topical", "Daily to every other day"],
        ["Thymosin Alpha-1", "0.5–2 mg (flat dose, clinical)", "SC", "2–3× weekly"],
        ["Ipamorelin", "100–300 mcg/kg (rodent)", "SC or IV", "Once to twice daily"],
        ["CJC-1295 no-DAC", "100–300 mcg/kg (rodent)", "SC", "Once daily"],
        ["SS-31 / Elamipretide", "1–3 mg/kg (rodent)", "IV or SC", "Once daily"],
        ["NAD+", "Variable by route", "IV infusion", "Acute dosing in protocols"],
        ["Epithalon", "1–10 mg/kg (rodent)", "IP or SC", "Daily for defined cycles"],
        ["Semaglutide (research)", "0.1–0.3 mg/kg weekly (rodent)", "SC", "Once weekly"],
      ],
    },
    {
      type: "callout",
      text: "These ranges represent what has appeared in published research — not validated dosing standards. Significant variation exists across studies based on species, model, and endpoint. Always base protocol design on the most relevant published literature for your specific model and research question.",
    },
    {
      type: "heading",
      text: "Calculating Peptide Shelf Life Per Vial",
    },
    {
      type: "paragraph",
      text: "A common question in laboratory planning is how long a reconstituted vial remains usable. Several factors affect this:",
    },
    {
      type: "list",
      items: [
        "Bacteriostatic water (BAC water with 0.9% benzyl alcohol): extends shelf life to approximately 30 days at 4°C vs. sterile water (use within 24–72 hours)",
        "Freeze-thaw cycles: each freeze-thaw cycle introduces degradation; aliquot vials before freezing if multiple doses will be drawn",
        "Storage temperature: reconstituted peptides should be refrigerated (4°C) and protected from light; -20°C for longer-term storage of unused lyophilized vials",
        "Peptide-specific stability: some compounds (e.g., TB-500 in saline) remain stable longer; others (e.g., GHK-Cu) are more susceptible to oxidation",
      ],
    },
    {
      type: "paragraph",
      text: "For multi-dose studies, calculate the number of doses per vial and ensure each vial is used within its stability window. If a single 5 mg vial reconstituted to 2,500 mcg/mL delivers 250 mcg doses, it contains 20 doses. At 2 doses/day, that vial should be consumed within 10 days — well within the 30-day BAC water stability window.",
    },
    {
      type: "divider",
    },
    {
      type: "disclaimer",
      text: "This article is for educational and research planning purposes only. All peptide compounds referenced are research chemicals intended for laboratory use by qualified researchers. Nothing in this article constitutes medical advice. Calculations should be verified by a qualified researcher before any research protocol is initiated.",
    },
  ],
};
